Inside, before eating.
Preparation of the suspension.
In a vial containing a powder, add 30 ml (or approximately 2/3 of the volume of the vial) of boiled and cooled to room temperature water. The vial is closed with a lid, turned over and shaken carefully until a uniform suspension is obtained. Add boiled and cooled water to a volume of 100 ml (until the label on the vial) and shake again. Before each intake, the contents of the vial should be shaken carefully until a uniform suspension is obtained. Single dose metered using the attached measuring spoon.
Single dose (depending on age):
| Age | Single dose of the drug, ml of suspension (mg of Umifenovir) |
| from 2 to 6 years | 10 ml (50 mg) |
| from 6 to 12 years | 20 ml (100 mg) |
| over 12 years and adults | 40 ml (200 mg) |
| Indication | Scheme of drug administration |
| In children from 2 years of age and adults: |
| Nonspecific prevention during the epidemic of influenza and other ARVI | in a single dose 2 times a week for 3 weeks. |
| Nonspecific prophylaxis in direct contact with patients with influenza and other ARVI | in a single dose once a day for 10-14 days. |
| Treatment of influenza and other acute respiratory viral infections in uncomplicated course | in a single dose 4 times a day (every 6 hours) for 5 days. |
| In children from 2 years: |
| Complex therapy of acute intestinal infections of rotavirus etiology | in a single dose 4 times a day (every 6 hours) for 5 days. |
For non-specific prophylaxis and treatment of severe acute respiratory syndrome (SARS):
For nonspecific prevention of SARS (in contact with the patient) in children from 6 years of age and adults:
children from 6 to 12 years old - 20 ml (100 mg), children over 12 years and adults - 40 ml (200 mg) once a day for 12-14 days.
For the treatment of SARS in children from 12 years of age and adults:
children over 12 years and adults - 40 ml (200 mg) 2 times a day for 8-10 days.